Women’s experiences of day-and-night closed-loop insulin delivery during type 1 diabetes pregnancy

Conor Farrington, Zoe Stewart, Roman Hovorka, Helen Murphy

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)
16 Downloads (Pure)


Aims: Closed-loop insulin delivery has the potential to improve day-to-day glucose control in type 1 diabetes pregnancy. However, the psychosocial impact of day-and-night usage of automated closed-loop systems during pregnancy is unknown. Our aim was to explore women’s experiences and relationships between technology experience and levels of trust in closed-loop therapy.

Methods: We recruited 16 pregnant women with type 1 diabetes to a randomized crossover trial of sensor-augmented pump therapy compared to automated closed-loop therapy. We conducted semistructured qualitative interviews at baseline and follow-up. Findings from follow-up interviews are reported here.

Results: Women described benefits and burdens of closed-loop systems during pregnancy. Feelings of improved glucose control, excitement and peace of mind were counterbalanced by concerns about technical glitches, CGM inaccuracy, and the burden of maintenance requirements. Women expressed varied but mostly high levels of trust in closed-loop therapy.

Conclusions: Women displayed complex psychosocial responses to day-and-night closed-loop therapy in pregnancy. Clinicians should consider closed-loop therapy not just in terms of its potential impact on biomedical outcomes but also in terms of its impact on users’ lives.
Original languageEnglish
Pages (from-to)1125-1131
Number of pages7
JournalJournal of Diabetes Science and Technology
Issue number6
Early online date5 Oct 2018
Publication statusPublished - Nov 2018

Cite this